Terms: = Breast cancer AND CEACAM5, CEA AND Treatment
382 results:
1. Implications of Pretreatment Serum Carcinoembryonic Antigen Levels and Perineural Invasion with Staging, Prognosis, and Management in Stage I-III Colon cancer after Surgery: A Retrospective Cohort Study in the SEER Database.
Zhang Q; Wang L; Sun R; Gao J; Liu T
Ann Ital Chir; 2024; 95(2):144-154. PubMed ID: 38684496
[TBL] [Abstract] [Full Text] [Related]
2. Potential Value of HSP90α in Prognosis of Triple-Negative breast cancer.
Wang HF; Chen Y; Cao B; Pei J
Med Sci Monit; 2024 Mar; 30():e943049. PubMed ID: 38553816
[TBL] [Abstract] [Full Text] [Related]
3. New ceaCAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.
Jancewicz I; Śmiech M; Winiarska M; Zagozdzon R; Wisniewski P
Cancer Immunol Immunother; 2024 Jan; 73(2):30. PubMed ID: 38279989
[TBL] [Abstract] [Full Text] [Related]
4. Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study.
Chi Y; Su M; Zhou D; Zheng F; Zhang B; Qiang L; Ren G; Song L; Bu B; Fang S; Yu B; Zhou J; Yu J; Li H
Elife; 2023 Nov; 12():. PubMed ID: 37929934
[TBL] [Abstract] [Full Text] [Related]
5. The Leser-Trélat Sign in a Patient with Gastric Adenocarcinoma.
Geber A; Hadžavdić A; Ljubojević Hadžavdić S
Acta Dermatovenerol Croat; 2023 Aug; 31(1):51-52. PubMed ID: 37843094
[TBL] [Abstract] [Full Text] [Related]
6. Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer.
Su Q; Wang X; Zhu R; Liu C; Sun S
Sci Rep; 2023 Sep; 13(1):14791. PubMed ID: 37684327
[TBL] [Abstract] [Full Text] [Related]
7. MOF-Based Biosensors for the Detection of Carcinoembryonic Antigen: A Concise Review.
Ibrahim MR; Greish YE
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630221
[TBL] [Abstract] [Full Text] [Related]
8. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal cancer and Invasive breast cancer.
Cao Y; Efetov SK; He M; Fu Y; Beeraka NM; Zhang J; Zhang X; Bannimath N; Chen K
Arch Immunol Ther Exp (Warsz); 2023 Aug; 71(1):19. PubMed ID: 37566162
[TBL] [Abstract] [Full Text] [Related]
9. Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma.
Nakayama I; Takahari D; Chin K; Wakatsuki T; Takamatsu M; Yamamoto N; Ogura M; Ooki A; Fukuda K; Osumi H; Fukuoka S; Shinozaki E; Yamaguchi K
ESMO Open; 2023 Aug; 8(4):101582. PubMed ID: 37348349
[TBL] [Abstract] [Full Text] [Related]
10. [Biomarkers for early screening and diagnosis of breast cancer: a review].
Liang Y; Hao M; Guo R; Li X; Li Y; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1425-1444. PubMed ID: 37154315
[TBL] [Abstract] [Full Text] [Related]
11. Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer.
Yin L; Chen GL; Xiang Z; Liu YL; Li XY; Bi JW; Wang Q
Biomed Pharmacother; 2023 Jun; 162():114648. PubMed ID: 37023621
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic role of heart rate variability in breast cancer and its relationship with peripheral serum carcinoembryonic antigen.
Ding L; Yang Y; Chi M; Chen Z; Huang Y; Ouyang W; Li W; He L; Wei T
PLoS One; 2023; 18(4):e0282221. PubMed ID: 37023015
[TBL] [Abstract] [Full Text] [Related]
13. Integrated SERS-Vertical Flow Biosensor Enabling Multiplexed Quantitative Profiling of Serological Exosomal Proteins in Patients for Accurate breast cancer Subtyping.
Su X; Liu X; Xie Y; Chen M; Zheng C; Zhong H; Li M
ACS Nano; 2023 Feb; 17(4):4077-4088. PubMed ID: 36758150
[TBL] [Abstract] [Full Text] [Related]
14. Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal cancer.
Chidimatsu H; Tsunedomi R; Nakagami Y; Xu M; Nakajima M; Nakashima-Nakasuga C; Tomochika S; Yoshida S; Suzuki N; Watanabe Y; Matsui H; Shindo Y; Tokumitsu Y; Iida M; Takeda S; Ioka T; Ueno T; Tanabe T; Hoshii Y; Hazama S; Nagano H
Anticancer Res; 2023 Jan; 43(1):105-114. PubMed ID: 36585204
[TBL] [Abstract] [Full Text] [Related]
15. Dual-Channel Detection of breast cancer Biomarkers CA15-3 and cea in Human Serum Using Dialysis-Silicon Nanowire Field Effect Transistor.
Li H; Wang S; Li X; Cheng C; Shen X; Wang T
Int J Nanomedicine; 2022; 17():6289-6299. PubMed ID: 36536938
[TBL] [Abstract] [Full Text] [Related]
16. Actual over 3-year survival after stereotactic body radiation therapy in patients with unresectable intrahepatic cholangiocarcinoma.
Zhang XX; Ma HB; Li TH; Huang B; Jia NY; Meng Y
Clin Transl Oncol; 2023 Mar; 25(3):731-738. PubMed ID: 36401766
[TBL] [Abstract] [Full Text] [Related]
17. Epidemiology of breast cancer in Mexican Women with Obesity as a Risk Factor.
Cejudo-Arteaga S; Guerrero-Ramos MÁ; Kuri-Exome R; Martínez-Cordero E; Farias-Serratos F; Maldonado-Vega M
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142655
[TBL] [Abstract] [Full Text] [Related]
18. Blood Test for breast cancer Screening through the Detection of Tumor-Associated Circulating Transcripts.
Park S; Ahn S; Kim JY; Kim J; Han HJ; Hwang D; Park J; Park HS; Park S; Kim GM; Sohn J; Jeong J; Song YU; Lee H; Kim SI
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012405
[TBL] [Abstract] [Full Text] [Related]
19. Circulating Tumor DNA as a Biomarker for Monitoring Patients with Solid cancers: Comparison with Standard Protein Biomarkers.
Duffy MJ; Crown J
Clin Chem; 2022 Nov; 68(11):1381-1390. PubMed ID: 35962648
[TBL] [Abstract] [Full Text] [Related]
20. Biomarker Profiling Revealed Carcinoembryonic Antigen as a Target of Artesunate in a Ductal breast cancer Patient.
Saeed MEM; Drif AI; Efferth T
Anticancer Res; 2022 Jul; 42(7):3483-3494. PubMed ID: 35790273
[TBL] [Abstract] [Full Text] [Related]
[Next]